Search results
Guardant Health's blood test to detect deadly colon cancer is under review by the FDA
Quartz· 5 days agoA U.S. Food and Drug Administration (FDA) advisory committee is meeting today to review a new blood...
How systems could double colorectal cancer screenings
Becker's ASC Review· 6 days agoGiving patients more choice in their colorectal cancer screening options could double the number of patients who get screened, according to a new study ...
Dr. Roach: The risk of colorectal cancer among young people is rising
St. Louis Post-Dispatch· 6 days agoDr. Roach: I read in the paper that the rate of colorectal cancer has been rapidly rising since the 1990s among adults younger than 50. The risk of developing ...
Guardant Stock Climbs As Cancer Test Strides Towards FDA Ok
The Wall Street Journal· 4 days agoShares of Guardant Health were up 8% Friday morning after an advisory panel to the U.S. Food and...
Guardant wins FDA AdCom backing for colon cancer test
Medical Device Network via Yahoo Finance· 4 days agoThe FDA AdCom voted 7-2 in favour of the Shield test stating that the test’s potential benefits...
Panel recommends blood test to detect colon cancer for FDA approval
UPI· 5 days agoMay 23 (UPI) -- A panel of U.S. Food and Drug Administration advisers on Thursday recommended...
I listened to my gut during pregnancy. It saved my life and fertility
Newsweek· 1 day agoUnfortunately, my symptoms were dismissed by my doctors on multiple occasions and considered part of...
2 conflicting colonoscopy guidelines
Becker's ASC Review· 6 days agoThe jury is still out on several guidelines regarding screening colonoscopies, despite rising colorectal cancer rates. Colorectal < ...
Personal View: What I wish Ohioans knew about screening for colon cancer
Crain's Cleveland Business· 7 days agoIncreased dialogue around this spike in colorectal cancer is welcomed and much-needed, given that recent surveys show about 30% of Ohioans haven’t received ...
FDA panel recommends approval of a blood test for colon cancer
NBC NEWS· 5 days agoThe panel voted seven-to-two in favor of benefits outweighing risks when using the test called...